Workflow
Inari Medical(NARI)
icon
Search documents
Inari Medical(NARI) - 2020 Q3 - Quarterly Report
2020-11-12 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to ___________ Commission File Number: 001-39293 Inari Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 45-2902923 ( ...
Inari Medical (NARI) Investor Presentation - Slideshow
2020-08-13 18:03
MEDICAL Investor Presentation NASDAQ: NARI August 2020 This presentation (together with any other statements or information that we may make in connection therewith) may contain are forward-looking statements. All statements other than statements of historical fact could be deemed forward-looking, including any estimates of our total addressable market, future results of operations, financial position, research and development costs, capital requirements and our needs for additional financing; our business ...
Inari Medical(NARI) - 2020 Q2 - Earnings Call Transcript
2020-08-12 02:23
Inari Medical, Inc. (NASDAQ:NARI) Q2 2020 Results Earnings Conference Call August 11, 2020 4:30 PM ET Company Participants Caroline Corner - Investor Relations Bill Hoffman - President & Chief Executive Officer Mitch Hill - Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Bob Hopkins - Bank of America Securities Larry Biegelsen - Wells Fargo Bill Plovanic - Canaccord Operator Ladies and gentlemen, thank you for standing by. And welcome to the Inari Medical Inc Second Quarter ...
Inari Medical(NARI) - 2020 Q2 - Quarterly Report
2020-08-11 20:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to ___________ Commission File Number: 001-39293 Inari Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 45-2902923 ( Stat ...